Cliquez ici pour lire en français
Artificial intelligence is opening new possibilities in breast cancer screening. It can flag an anomaly before symptoms appear, scan medical images in moments and help a specialist refine their reading. But behind the technical progress, patient acceptance remains a serious open question. In Cameroon, where screening still runs into barriers of access and information, the arrival of these tools could change how women relate to medical exams.
Asked about the technology, some women say AI could be one more tool for catching the disease earlier. Others are uneasy about handing their results to a machine. Between trust in medical staff, fear of mistakes and worries about the cost of care, the innovation meets a reality in which technology doesn’t always reassure.
A machine backing up the doctor 🎀
In medicine, AI is notably used to analyze images from exams such as mammography. Some software can spot suspicious areas and help radiologists identify anomalies that deserve a closer look. The goal is to supplement medical expertise, not to routinely replace the professional who interprets the results.
That could appeal to women who want more effective screening. But putting a machine into a medical pathway doesn’t necessarily inspire the same confidence as seeing a doctor. For a patient, understanding what the technology actually does can make all the difference.
« If someone explains that the machine helps the doctor examine the images better, I can see why it’s useful. But I would still want the doctor to check the results and explain what they mean, » says Odile Motto.
That reservation points to a clear expectation. Patients can be interested in technological progress without wanting their relationship with the care team to vanish behind a screen.
Trust comes first 🤖
Being told you may have an anomaly is frightening enough. A result produced with the help of AI may be hard to accept for a woman who doesn’t understand how the machine reached its conclusion.
Fear of error also shapes how these tools are perceived. Software can flag an anomaly that turns out not to be cancer, or miss a lesion entirely. Its performance depends on the technology used, the data it was trained on and the conditions in which it is deployed.
« When it comes to my health, I wouldn’t want to be told simply that the computer found nothing. I’d rather the doctor examine me and confirm I don’t need other tests, because you still need a manual exam to be sure, » explains Lidienne Mbolle.
These concerns show that trust doesn’t rest on AI’s technical capabilities alone. It also depends on how transparent health professionals are, on whether results are checked, and on whether patients can get explanations they can follow.
Access to screening is the deciding factor 💗
These technologies would arrive in a context where access to medical exams is still a concern. For some women, the cost of screening, the trips to health facilities and the lack of information can delay a consultation.
A study of 475 women in Cameroon’s North region found that the cost of mammography was a barrier to screening for some participants. The results reflect a regional population, but they point to difficulties that any discussion of access to care has to take into account.
In that light, AI is not just a medical innovation. Any future use raises the question of who can actually reach it. If the necessary equipment sits in only a handful of facilities, the technology could fail to benefit all women.
« It would be interesting if this technology could detect the disease earlier. But exams would also need to stay affordable. Many women already have to think twice before spending money on a consultation. If there are no free campaigns like the ones in October, it gets complicated, » says Laure Bana, a trader. She is referring to the free screening campaigns held each October, Breast Cancer Awareness Month.
Explain it in plain terms 🩺
Using AI in screening also takes an effort to explain. For patients, the term itself can sound complicated and suggest that a machine alone is making a medical decision. A clear account of its role would help separate automated image analysis from the diagnosis made by the health professional.
« If someone takes the time to explain how it works and the doctor stays responsible for my follow-up, I would feel more reassured. What matters to me is understanding what is being done and knowing who to turn to if the result reveals something. Let’s be honest, it’s now impossible to do without technology, » says Melanie Ekoue.
Through these views, the women interviewed show that medical support remains essential, especially when results call for further tests. AI can help analyze images, but it replaces neither the conversation with the patient nor attention to her clinical situation.
Between technological progress and patient expectations 🇨🇲
AI could help improve breast cancer screening in Cameroon. Whether it is adopted will depend on patients’ trust, on the doctor’s role in interpreting results and on how affordable exams are.
To be accepted, the technology will need to be presented clearly and used as a support tool for medical staff. Beyond its performance, its value will lie in helping women without making access to care even harder.
Would you accept an AI taking part in breast cancer screening, and why? Tell us in the comments.🎀
📱 Get our latest updates every day on WhatsApp, directly in the “Updates” tab by subscribing to our channel here ➡️ TechGriot WhatsApp Channel Link 😉
